Posfrea
Product Images NDC 83831-104

8 FDA label images from Avyxa Pharma, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Posfrea (NDC 83831-104). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avyxa Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (31e6e672 Bc75 4bb0 88ea Fdb864aff275 01)

Image (31e6e672 Bc75 4bb0 88ea Fdb864aff275 01)
Chemical structure of the active ingredient shown with a hydrochloride (HCl) salt, associated with posfrea 0.25 mg/5 mL by Avyxa Pharma, LLC.*
FDA Label Image

Image (4cb4c4f2 1072 45f9 Bd4d 09e3fc2ddaaf 66 2)

Image (4cb4c4f2 1072 45f9 Bd4d 09e3fc2ddaaf 66 2)
A vertical dot plot chart showing differences in complete response rates with confidence intervals. The x-axis represents the difference in complete response rates, ranging from -10 to 35 percent. The y-axis has no visible label, and the data points show values with associated error bars, for example, 2% (23), -2% (22), and -9% (13). This chart likely compares response rates between treatment groups or conditions.*
FDA Label Image

Image (4cb4c4f2 1072 45f9 Bd4d 09e3fc2ddaaf 68 2)

Image (4cb4c4f2 1072 45f9 Bd4d 09e3fc2ddaaf 68 2)
A chart illustrating differences in complete response rates with two data points marked as [8%, 30%] and [3%, 27%], plotted against the x-axis labeled 'Difference in Complete Response Rates' ranging approximately from -10 to 35.*
FDA Label Image

Image (4cb4c4f2 1072 45f9 Bd4d 09e3fc2ddaaf 70 2)

Image (4cb4c4f2 1072 45f9 Bd4d 09e3fc2ddaaf 70 2)
A bar chart illustrating the difference in complete response rates. The horizontal axis presents the percentage difference, ranging approximately from -10 to 35%.*
FDA Label Image

Image (2f9cbcbc 86ee 49e4 A98a D7fa286a32b8 113 1)

FDA Label Image

Image (2f9cbcbc 86ee 49e4 A98a D7fa286a32b8 86 2)

FDA Label Image

Posfrea (palonosetron) Injection, 0.25mg/5 mL -container Label (31e6e672 Bc75 4bb0 88ea Fdb864aff275 02)

Posfrea (palonosetron) Injection, 0.25mg/5 mL -container Label (31e6e672 Bc75 4bb0 88ea Fdb864aff275 02)
Label for Posfrea (palonosetron) Injection 0.25 mg/5 mL (0.05 mg/mL) single-dose vial. The label includes storage instructions, manufacturer information (Avyxa Pharma, LLC), NDC 83831-105-01, and indicates the product is made in India. It is for intravenous use.*
FDA Label Image

Posfrea (palonosetron) Injection, 0.25mg/5 mL -carton Label (31e6e672 Bc75 4bb0 88ea Fdb864aff275 03)

Posfrea (palonosetron) Injection, 0.25mg/5 mL -carton Label (31e6e672 Bc75 4bb0 88ea Fdb864aff275 03)
Posfrea (palonosetron) Injection 0.25 mg/5 mL (0.05 mg/mL) is shown in a flat carton packaging label manufactured for Avyxa Pharma, LLC. The label includes dosage form as a 5 mL single dose vial for intravenous use. The color scheme incorporates black text with a blue highlight on dosage and a red-orange wave design near the bottom. Storage information and active ingredient contents are detailed on the label. The labeler logo and barcode are present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.